Medical Oncologist
After surgery
Escalating treatment after residual disease: what is offered
If cancer was still present when your breast tissue was examined, additional treatment after surgery has been shown to lower the chance of it returning. It is offered because of that specific finding, not because anything went wrong. This page explains what is offered for each subtype, where the evidence came from, and what to ask before agreeing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
On this page
- Why am I being offered more treatment after surgery?
- What is offered, by subtype
- How this became standard treatment
- The vocabulary, in plain language
- What the added treatment usually involves
- What it offers, and what it costs you
- What families take from being offered more treatment
- Common questions about treatment after residual disease
The short answer
Why am I being offered more treatment after surgery?
Because cancer was still present when your breast tissue was examined. Where that happens, additional treatment after surgery has been shown to lower the chance of the cancer returning. It is offered because of that specific finding, not because something went wrong.
Why this only became possible recently
Until chemotherapy was routinely given before surgery, nobody knew which cancers had responded and which had not. Measuring the response created a group who could be identified as needing more, and trials then tested giving them extra treatment. Those trials are why you are being offered it.
What is offered depends on your subtype
Triple negative cancers and HER2 positive cancers each have their own established approach, and they are different from one another. Hormone sensitive cancers are handled differently again, with tablets doing the long-term work.
It is additional, not a replacement
Radiotherapy still happens if it was planned. Hormone tablets still continue if your cancer is receptor positive. This treatment is added alongside the rest of the plan rather than instead of any of it.
Ask which treatment applies to your subtype, how long it lasts, and what it is expected to add.The options
What is offered, by subtype
These are different treatments for different cancers. Only one of them will apply to you.
Triple negative
An oral chemotherapy tablet taken in cycles for several months after surgery is the established approach where cancer remained. It is taken at home rather than through a drip.
HER2 positive
The HER2 treatment given after surgery is usually switched to a different one rather than continuing what you had before. This change is made directly on the basis of the residual disease result.
Ask which HER2 treatment you are now on.Hormone sensitive
Tablets remain the mainstay and run for years. For women with higher-risk features, an additional targeted tablet is sometimes added alongside them for a defined period.
If you carry a BRCA fault
A further targeted treatment may be offered after surgery. This applies across subtypes and is a reason to make sure genetic testing has actually been done.
Ask about testing if
- You were diagnosed young
- Your cancer is triple negative
- There is breast or ovarian cancer in the family
Where this comes from
How this became standard treatment
-
Chemotherapy before surgery became routine
For the subtypes where it works well, giving treatment first became the normal approach, mainly to allow smaller operations.
-
A pattern was noticed
Women whose cancer cleared completely did markedly better than those with cancer remaining. The difference was consistent enough to identify a group who needed more.
-
Trials tested giving that group extra treatment
Women with cancer remaining after surgery were allocated at random to receive additional treatment or the standard care of the time, then followed for years.
-
The extra treatment worked
Fewer recurrences in the groups who received it, in both triple negative and HER2 positive disease. The findings changed practice internationally.
-
It became the standard offer
Which is why your team is recommending it now. It is established treatment rather than something experimental, and it is why the response was measured in the first place.
Words you will hear
The vocabulary, in plain language
- Residual disease
- Invasive cancer still present in the tissue removed at surgery. The finding that leads to this conversation.
- Escalation
- Adding treatment because the response was incomplete. The word your team may use for what is being proposed.
- Adjuvant
- Given after surgery. Neoadjuvant means the same treatment given before.
- Oral chemotherapy
- Chemotherapy taken as tablets at home rather than through a drip. It is still chemotherapy, with real side effects.
- Antibody-drug conjugate
- A targeted treatment that carries chemotherapy directly to cells showing a particular marker, limiting what reaches healthy tissue.
- Disease-free survival
- The measure these trials used: how long people go without the cancer returning.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Side by side
What the added treatment usually involves
Oral chemotherapy tablets
Targeted treatment by drip
Taken at home, in cycles
Given at the day-care unit
Sore hands and feet, loose motions, tiredness
Tiredness, low counts, occasional nerve symptoms
Blood tests between cycles
Blood tests and heart checks during treatment
Several months
Usually completing a year of HER2 treatment
Fewer hospital visits
Regular scheduled visits
Being straight with you
What it offers, and what it costs you
These treatments reduce the chance of the cancer returning. They do not remove it. Your oncologist should be able to tell you roughly what benefit is expected in your situation, and you are entitled to ask for that before agreeing.
The side effects are real
Oral chemotherapy is still chemotherapy. Sore, peeling hands and feet are common enough to affect daily life and are the usual reason doses are reduced. Tell your team early, because a dose adjustment is far better than stopping altogether.
Months more treatment is hard
You have already finished chemotherapy and surgery and expected to be done. Being told there is more is demoralising in a way that is rarely acknowledged. Say so to your team rather than absorbing it quietly.
What this page cannot tell you
It cannot tell you your own numbers. The benefit depends on your subtype, how much cancer remained and what else you are receiving. Ask for your own figures, ask what happens if you decline, and ask whether a trial is open to you.
Commonly believed
What families take from being offered more treatment
More treatment means the situation is desperate.
It means the situation is understood well enough to act on. This treatment is given with the intention of clearing the cancer completely, and it exists because trials showed it lowers the chance of recurrence in exactly your situation.
The first chemotherapy must have been the wrong choice.
There is no way to know in advance which cancers will clear completely, which is why the response is measured rather than predicted. The first course shrank the cancer and produced the information now shaping your treatment.
Tablets are gentler, so they are a lower dose of treatment.
Oral chemotherapy is genuine chemotherapy with genuine side effects, particularly on the hands and feet. Taking it at home makes it more convenient, not milder. Report side effects as you would with any drip treatment.
She has been through enough, we should stop here.
That is a real choice and it belongs to the patient. Make it with the numbers in front of you rather than from exhaustion. Ask what benefit is expected and what declining would mean, then decide. Dose reductions and breaks are also possible.
Questions we are asked
Common questions about treatment after residual disease
How much difference does this actually make?
Enough that it changed practice internationally, and the benefit is largest in triple negative and HER2 positive disease where cancer remained. Your own figure depends on how much was left and what else you are having. Ask your oncologist to put a number on it for your situation rather than relying on general statements.
Can I refuse it?
Yes, and the decision is yours. Ask what benefit is expected, what the side effects are likely to be for you, and what the plan would be without it. A reduced dose or a shorter course is sometimes a reasonable middle path, so ask about that before choosing between all or nothing.
Does this delay my radiotherapy?
Your team sequences the two, and the order depends on what is being given. Sometimes they overlap, sometimes one follows the other. Ask for the full schedule in writing so you can see how the next several months fit together.
What are the main side effects of the tablets?
Sore, red and peeling skin on the palms and soles is the most common and the usual reason doses are reduced. Loose motions, mouth soreness and tiredness also occur. Moisturise the hands and feet from the first day and report skin changes early rather than waiting for your next visit.
Will I need heart monitoring?
If you are having HER2-directed treatment, yes, your heart function is checked at intervals throughout. It is a routine precaution rather than a sign of a problem, and any change is usually reversible if picked up early. Ask how often yours will be checked.
Should I ask about a clinical trial?
Yes. This is one of the most actively researched situations in breast cancer, and trials frequently recruit women with cancer remaining after surgery. Ask before your treatment after surgery is finalised, because eligibility often depends on not having started something else.
Do I still take hormone tablets as well?
If your cancer is receptor positive, yes. They continue for years and do the long-term work. The added treatment sits alongside them rather than replacing them. Make sure you know what you are taking, for how long, and who to ask about side effects.
Has my genetic testing been done?
Check, because a BRCA result can open a further targeted treatment after surgery. If it has not been arranged and you were diagnosed young, have triple negative disease or a family history, ask for a referral now rather than after your treatment plan is settled.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Treatment after breast cancer surgery
- National Cancer Institute — Breast cancer treatment (PDQ)
- Breast Cancer Now — Treatment after surgery
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.